drugset / Trial / NCT03931876

A Single Ascending Dose Study of AV-006 in Healthy Subjects

NCT03931876 ↗

Phase 1 Unknown 40 enrolled Arixa Pharmaceuticals
RandomizedSequentialQuadruple-blindTreatment

Summary

Characterization of the single dose pharmacokinetics of AV-006 in healthy male and female subjects. Description of safety and tolerability of AV-006 in healthy subjects

Timeline

Start
2019-06-24
Primary completion
2019-09-01
Completion
2019-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator AV-006 Unknown — Oral